Chronic Myeloid Leukemia Coverage from Every Angle
Advertisement
Advertisement

Recent News

Ruxolitinib for Rare BCR-ABL1–Negative Myeloid Neoplasms
2020 CML Treatment Recommendations From European LeukemiaNet
TAT 2020: Adding Diabetes Drug to Imatinib Therapy for CML
Characterizing a Regulatory Axis in CML Cell Apoptosis
Common Clover Plant May Harbor Anti-CML Compounds
Can TKIs Combined With Interferon-α Enhance Immunosuppressive State in CML?
Effect of Hydroxyurea and Imatinib on Major Molecular Response in CML
Genetic Mutations in CML and Predicting Response to TKI Therapy
Early Detection of Kinase Domain Mutations in Chronic Phase CML
Nilotinib Plus Pegylated Interferon in First-Line Treatment of CML
Minimum Effective Dose of Second-Line Bosutinib in Elderly Patients With CML
Is Pregnancy Safe for Patients Under Treatment for CML?
Real-World Ponatinib Outcomes in Patients With CML From Nationwide Belgian Registry
Immunologic Identifiers May Be Related to Relapse in Chronic Myeloid Leukemia
ASH 2019: Blast Thresholds in CML and High-Risk Additional Chromosomal Abnormalities
ASH 2019: Nilotinib Plus Pegylated IFN Alpha 2a Therapy for Chronic Phase CML
ASH 2019: Gene-Expression Model May Predict Deep Molecular Response in CML
ASH 2019: Tyrosine Kinase Inhibitor Discontinuation in Pediatric Patients With CML
ASH 2019: Predicting Treatment-Free Remission After Cessation of TKIs in CML
ASH 2019: Predicting Successful Treatment-Free Remission in Patients With CML
Heterogeneous Genetic Alterations in CML: Therapeutic Implications
Can a Drug Approved for CML Affect Treatment of Degenerative Brain Diseases?
Update on Antitumor Activity of Natural Killer Cells in CML
Bone Marrow Molecule in Elimination of CML Stem Cells
TKI Initiation and Health-Care Costs for Patients With CML
Long-Term Patterns of Oral Anticancer Therapy Use in Patients With CML
ESMO 2019: Significance of BCR-ABL Transcript Variants in Chronic Phase CML


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.